The presence of chymase in human kidneys suggests a bypass of the inhibitory effect of ACE inhibitors on Ang II levels in humans, which might gain importance in pathologic conditions like CKD, where cellular re-organization of the kidney structure occurs. Here, CMA1 is linked to chronic kidney disease.